New FDA-approved drug offers hope in pancreatic cancer treatment
· 20 min
Episode New FDA-approved drug offers hope in pancreatic cancer treatment
The Food and Drug Administration approved a new medication to treat pancreatic cancer. In trials, it extended the survival rate of patients by a median of 13.2 months. Dr. Brian Wolpin from the Dana Farber Cancer Institute explains how the drug works and what it could mean for the future of cancer treatment. Then, a recent study found that at least a quarter of former NFL players who died had chronic traumatic encephalopathy, or CTE. Chris Nowinski, CEO of the Concussion Legacy Foundation shares more about the findings and how they could impact the upcoming football season. And, in Nepal, first responders are searching for survivors after a massive flash flood killed at least 300 people. Suraj Sigdel, Nepal Country Director for Mercy Corps, describes the work he and others are doing on the ground. See pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences. NPR Privacy Policy
Links in the notes 2
Shows are listed from Apple Podcasts' charts and directory, and Podcast Index where it is used. Every show and episode belongs to its publisher and plays from the publisher's own feed; this site hosts none of them. Explicit shows are for adult profiles only, and children’s profiles hear only children’s shows. More about this list.